Ibritumomab Intravenous and Promacot
Determining the interaction of Ibritumomab Intravenous and Promacot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: promethazine
Brand name: Phenergan, Phenadoz, Promethegan
Synonyms: Promethazine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Promacot Injection, Intravenous
- Ibritumomab Intravenous-Promacta
- Ibritumomab Intravenous-Promacta (Eltrombopag Powder for Suspension)
- Ibritumomab Intravenous-Promacta (Eltrombopag Tablets)
- Ibritumomab Intravenous-Promethazine
- Ibritumomab Intravenous-Promethazine and Phenylephrine
- Promacot-Ibritumomab Tiuxetan
- Promacot-Ibrutinib
- Promacot-Ibrutinib Capsules
- Promacot-Ibrutinib Tablets
- Promacot-Ibu
- Promacot-IBU Tablets